Publications by authors named "Giampiero Gubbiotti"
Transplantation
November 2009
Article Synopsis
- - The study aimed to assess if higher doses of the drug everolimus (EVL) could allow for a reduced dosage of cyclosporine A (CsA) in kidney transplant patients, potentially lowering the risk of kidney dysfunction.
- - Two groups of new kidney transplant recipients were compared: one received standard EVL levels with lower CsA, and the other received higher EVL levels with very low CsA. The main outcomes measured were kidney function (creatinine clearance) and rates of acute rejection after 6 months.
- - Results showed that while there was better graft survival in the higher EVL group, overall kidney function and rejection rates at 6 and 12 months did not differ significantly between the two
